Dr. Jacob Gottlieb was the former CIO of Visium Asset Management which he co-founded in 2005 with close friends and members of his family. Visium Asset Management grew exponentially under Gottlieb’s leadership. At one point in time, Visium had offices in London, New York, and San Francisco with an investment fund of $8 billion dollars.
Dr. Gottlieb carried a reputation for investing and growing lucrative fund portfolios, therefore it was easy for him to earn the trust of other prominent investors. However, in 2016 Visium Asset Management came crumbling down. Several Visium management staff members were charged with insider trading, creating returns that did not exist and inflating various management fees.
Dr. Gottlieb had to close the company because of the stampede among investors and Visium employees. But, it is hard to keep a good man down! Dr. Jacob Gottlieb was not held responsible for the sins committed by a few unscrupulous employees, thus he founded a new firm called Altium Capital.
Retaining his reputation as a leading healthcare investor, Jacob Gottlieb began rebuilding his investment portfolio with investments in Oramed Pharmaceuticals, Inc., and Sellas Life Sciences. His Altium Capital offices are located in New York City which he shares with Iguana Healthcare Partners and Bay City Capital.
Both Oramed and Sellas are very innovative pharmaceutical companies who already have produced products that are in the final stages of an FDA approval process. They are also the first decisive investments by Dr. Gottlieb as he continues the next-stage in his entrepreneurial ventures.
David Gottlieb began his interest in investing when he won a stock picking contest at his high school. He thought that he wanted to study medicine, so he graduated Magna Cum Laude from Brown University and received his medical degree from NYU Medical School. However, after completing his internship he lost interest in medicine and turned to Wall Street.
Dr. Gottlieb began his young financial career at Sanford C. Bernstein & Co., while also working to achieve his Certified Financial Analyst designation. After Sanford, Gottlieb became a healthcare portfolio manager at Merlin Biomed Group, followed by a massive climb upward at the Balyasny Asset Management where he became the firms’ top-earning agent and which then led to his work with Visium.